|
English
|
正體中文
|
简体中文
|
Total items :2823024
|
|
Visitors :
30227407
Online Users :
898
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"han cp"
Showing items 1-10 of 18 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients
|
Chao, WR; Lee, YJ; Lee, MY; Sheu, GT; Han, CP |
| 中山醫學大學 |
2020 |
The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases
|
Chiu, HH; Chao, WR; Chen, CK; Lee, YJ; Lee, MY; Han, CP |
| 臺北醫學大學 |
2014 |
Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix
|
Wu, CH;Ko, JL;Chen, SC;Lin, YW;Han, CP;Yang, TY;Chien, MH;Wang, PH |
| 中山醫學大學 |
2010 |
Anti-cytokeratin CAM 5.2 is specific for K8 and to a lesser extent for the closely related K7, but shows no reactivity with K18 or K19: comment on: "keratin expression in endocrine organs and their neoplasms" Endocr Pathol.
|
Chen PJ;Hsu JD;Han CP |
| 中山醫學大學 |
2010 |
Anti-cytokeratin CAM5.2 reagent (Becton Dickinson Biosciences) can detect CK 8, not CK8/18-Comment on "Sonographic findings in a patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor," J Clin Ultrasound 2010 Jan 20 [Epub ahead of print].
|
Chen, PJ; Hsu, JD; Han, CP |
| 中山醫學大學 |
2010 |
HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.
|
Han, CP; Hsu, JD; Yao, CC; Lee, MY; Ruan, A; Tyan, YS; Yang, SF; Chiang, H |
| 中山醫學大學 |
2010 |
The murine monoclonal antibody anti-cytokeratin CAM 5.2 is specific for intracellular cytokeratin 8, not cytokeratin 18.
|
Cheng, WC; Hsu, JD; Yao, CC; Han, CP |
| 中山醫學大學 |
2010 |
Becton Dickinson Biosciences CAM5.2 does not stand for true CK8/18. Comment on "Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin", Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:763-7.
|
Wu, YL; Huang, YF; Hsu, JD; Han, CP |
| 中山醫學大學 |
2010 |
Anti-Cytokeratin CAM5.2 (BD) does not act as a substitute of the CK8/18 monoclonal antibody. Comment on: 'Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma'. Histopathology 2009; 54; 607-613.
|
Hsu, JD; Yao, CC; Yuan, CC; Lai, CR; Ting, LT; Li, YJ; Han, CP |
| 中山醫學大學 |
2010 |
BD (Becton, Dickinson and Company) Biosciences manufactures anticytokeratin CAM5.2, not CK8/18 monoclonal antibody.
|
Liao, CL; Tzeng, SL; Hsu, JD; Chen, PJ; Han, CP |
Showing items 1-10 of 18 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
